267 related articles for article (PubMed ID: 24815488)
1. Differentially expressed proteins in ER+ MCF7 and ER- MDA- MB-231 human breast cancer cells by RhoGDI-α silencing and overexpression.
Hooshmand S; Ghaderi A; Yusoff K; Thilakavathy K; Rosli R; Mojtahedi Z
Asian Pac J Cancer Prev; 2014; 15(7):3311-7. PubMed ID: 24815488
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of RhoGDIα increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells.
Hooshmand S; Ghaderi A; Yusoff K; Karrupiah T; Rosli R; Mojtahedi Z
Cell Adh Migr; 2013; 7(3):297-303. PubMed ID: 23563506
[TBL] [Abstract][Full Text] [Related]
3. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Jiang Q; Zhang H; Zhang P
J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
[TBL] [Abstract][Full Text] [Related]
4. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
5. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
Lim JP; Shyamasundar S; Gunaratne J; Scully OJ; Matsumoto K; Bay BH
BMC Cancer; 2017 Mar; 17(1):201. PubMed ID: 28302118
[TBL] [Abstract][Full Text] [Related]
6. A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor.
Bian YL; Qi YX; Yan ZQ; Long DK; Shen BR; Jiang ZL
Eur J Cell Biol; 2008 Feb; 87(2):101-10. PubMed ID: 17963997
[TBL] [Abstract][Full Text] [Related]
7. 17beta-hydroxysteroid dehydrogenase type 1 modulates breast cancer protein profile and impacts cell migration.
Aka JA; Zerradi M; Houle F; Huot J; Lin SX
Breast Cancer Res; 2012 Jun; 14(3):R92. PubMed ID: 22691413
[TBL] [Abstract][Full Text] [Related]
8. RhoGDI deficiency induces constitutive activation of Rho GTPases and COX-2 pathways in association with breast cancer progression.
Bozza WP; Zhang Y; Hallett K; Rivera Rosado LA; Zhang B
Oncotarget; 2015 Oct; 6(32):32723-36. PubMed ID: 26416248
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma.
Wang H; Wang B; Liao Q; An H; Li W; Jin X; Cui S; Zhao L
FEBS Lett; 2014 Jan; 588(3):503-8. PubMed ID: 24374343
[TBL] [Abstract][Full Text] [Related]
10. The monoamine oxidase-A inhibitor clorgyline promotes a mesenchymal-to-epithelial transition in the MDA-MB-231 breast cancer cell line.
Satram-Maharaj T; Nyarko JN; Kuski K; Fehr K; Pennington PR; Truitt L; Freywald A; Lukong KE; Anderson DH; Mousseau DD
Cell Signal; 2014 Dec; 26(12):2621-32. PubMed ID: 25152370
[TBL] [Abstract][Full Text] [Related]
11. Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings.
Cigna D; D'Anna C; Zizzo C; Francofonte D; Sorrentino I; Colomba P; Albeggiani G; Armini A; Bianchi L; Bini L; Duro G
Mol Biosyst; 2013 Jun; 9(6):1162-8. PubMed ID: 23385635
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9.
Muñiz Lino MA; Palacios-Rodríguez Y; Rodríguez-Cuevas S; Bautista-Piña V; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; González-Santiago AE; Flores-Pérez A; Díaz-Chávez J; Carlos-Reyes Á; Álvarez-Sánchez E; López-Camarillo C
J Proteomics; 2014 Dec; 111():198-211. PubMed ID: 24768906
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of Rho guanine nucleotide dissociation inhibitor-alpha modulates the cytotoxic effect of busulfan in HEK293 cells.
Reimer J; Bien S; Sonnemann J; Beck JF; Wieland T; Kroemer HK; Ritter CA
Anticancer Drugs; 2007 Mar; 18(3):333-40. PubMed ID: 17264767
[TBL] [Abstract][Full Text] [Related]
15. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
16. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
[TBL] [Abstract][Full Text] [Related]
17. Rho GDP-dissociation inhibitor α is a potential prognostic biomarker and controls telomere regulation in colorectal cancer.
Huang D; Lu W; Zou S; Wang H; Jiang Y; Zhang X; Li P; Songyang Z; Wang L; Wang J; Huang J; Fang L
Cancer Sci; 2017 Jul; 108(7):1293-1302. PubMed ID: 28417530
[TBL] [Abstract][Full Text] [Related]
18. Propofol and bupivacaine in breast cancer cell function in vitro - role of the NET1 gene.
Ecimovic P; Murray D; Doran P; Buggy DJ
Anticancer Res; 2014 Mar; 34(3):1321-31. PubMed ID: 24596379
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 1B dephosphorylates Rho guanine nucleotide dissociation inhibitor 1 and suppresses cancer cell migration and invasion.
Cho HJ; Kim JT; Lee SJ; Hwang YS; Park SY; Kim BY; Yoo J; Hong KS; Min JK; Lee CH; Lim JS; Yoon SR; Choi I; Choe YK; Lee HG
Cancer Lett; 2018 Mar; 417():141-151. PubMed ID: 29307615
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3τ promotes breast cancer invasion and metastasis by inhibiting RhoGDIα.
Xiao Y; Lin VY; Ke S; Lin GE; Lin FT; Lin WC
Mol Cell Biol; 2014 Jul; 34(14):2635-49. PubMed ID: 24820414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]